Comparison of my two only single stock (rest ETF).
AMRN: Only 36% held by institutions - other than that a lot of strong numbers - in earnings cash etc. WHY' is SP - not a lot higher - with those numbers ?
MRVL: My other stock - a much nicer story - got in a little below $25. Even this company has some debt - 77% owned by institutions - hardly any shorting - and as investor IMPORTANT SP +$57. Revenue something like 4 times that of AMRN - still Net income negative. Cash about the same as Amarin.
Isolated comparing at these two companies - SP of Amarin should be minimum 1/3 of MRVL - meaning SP $18 right now - why are we barely hanging on to $4 ?
As many have said - something is missing' in valuation of Amarin - looking at the numbers - and potential for growth - where we are right now - simply does not add up.
Possibly the 63% retailers is part what it is all about, keep the SP depressing, to make longs give up.
And a continued 'held low' SP - does at the same time 'make a possible BO cheaper - and keeps this relatively small Bio Company with the potential Wonder Drug - under control.
Market Data 
Markets 
